Discover the innovative work being done by California Life Science member companies.

Voice of Member

Member News

Biointron

Biointron Insights: Antibody Industry Report (Q1 2025 Insights, Trends & Analysis)

By CLS Member: Biointron

04/09/25 – Biointron’s Q1 2025 antibody report aims to explore the events and trends of the biopharmaceutical industry in 2025 (January, February, March). This quarter, 6 novel monoclonal antibody drugs have been approved by at least one regulatory agency around the world: three from China, two from the EU, and one from Australia. Read more here!

Wacker Biotech Announces Strategic Collaboration with RNAV8 Bio to Enhance mRNA Therapeutics Development

By CLS Member: Wacker Biotech

04/03/25 – Wacker Biotech, a leading contract development and manufacturing organization (CDMO) wholly owned by Wacker Chemie AG, today announced a strategic collaboration with RNAV8 Bio, a Boston-based pioneer in mRNA engineering. The collaboration is aimed at progressing the development and production of mRNA-based advanced therapies for the biopharma industry. Read more here!

Why Sustainable Labs Can’t Wait

By CLS Member: Arcondis

03/27/25 – While global environmental change, including climate change, is now widely recognised, the healthcare sector has only recently begun to fully acknowledge its impact on the environment. The sector is still in the early stages of identifying necessary changes and taking actions to significantly address and reduce its impact. With time running out, the healthcare sector must urgently address sustainability. Read more here!

Pitching Gastroenterology Advancements QuickFire Challenge

By CLS Member: Johnson & Johnson

03/25/25 – We are proud to announce the launch of the Pitching Gastroenterology Advancements #QuickFireChallenge. This is your chance to showcase your ideas with potential to transform the future of gastrointestinal (GI) disease treatment. Innovators worldwide are invited to submit novel approaches to modulating gut barrier function and integrity towards achieving epithelial barrier homeostasis and healing, including novel approaches and targets to prevent or repair epithelial damage, and methods for assessing barrier function/dysfunction. Innovators with the most promising ideas will have an opportunity to showcase their science, either in person or virtually, to a panel of Johnson & Johnson Innovative Medicine Immunology leaders during the 2025 Digestive Disease Week (DDW) Conference in San Diego, CA, May 3-6, 2025. Read more here!

Sapio Sciences Makes AI-Native Drug Discovery Seamless with NVIDIA BioNeMo

By CLS Member: Sapio Sciences

03/19/25 – Sapio Sciences, the science-aware™ lab informatics platform, today announced the integration of the NVIDIA BioNeMo platform into the Sapio Lab Informatics Platform. This integration brings AI-driven computational drug discovery directly into Sapio ELN (Electronic Lab Notebook), helping to streamline workflows and improve decision-making in drug discovery. Read more here!

The Top 10 Questions You Should Be Asking Your CPA This Tax Season

By CLS Member: Withum

03/18/25 – Navigating the complex landscape of tax regulations in the life sciences and technology industries requires a knowledgeable CPA and a proactive approach to identifying tax-saving opportunities and ensuring compliance. Read more here!

Montara Therapeutics Closes $20M Oversubscribed Seed Expansion, Appoints Troy Wilson as Chairman of the Board

By CLS Member: Montara Therapeutics

03/13/25 – Montara Therapeutics, a biotech company pioneering brain-selective therapies for CNS diseases, today announced the closing of a $20 million oversubscribed expansion of its Series Seed financing. The round, which brings Montara’s total seed funding to $28 million, includes increased participation from all existing investors. Read more here!

Regeneron Science Talent Search 2025 Awards More Than $1.8 Million to High School Seniors for Innovative Scientific Research on Classifying Objects in Space, Treating a Rare Muscle Disease and Solving a Long-Standing Math Problem

By CLS Member: Regeneron Pharmaceuticals

03/11/25 – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) announced that Matteo Paz,18, of Pasadena, CA, won the top award of $250,000 in the 2025 Regeneron Science Talent Search, the U.S.’s oldest and most prestigious science and math competition for high school seniors. Read more here!

Submit Your Content

CLS members can submit articles, press releases, whitepapers, and/or blogs to be featured on the ‘Member Voice’ section of our website, which will also be amplified on CLS social media channels and could be spotlighted in our bi-weekly newsletter, CLS Bulletin*.

Learn more about all of the ways CLS elevates the voice of our members. Not yet a member? Join CLS today to start taking advantage of this exclusive member benefit.

Submit Your Content

To be eligible, organizations must meet the following criteria:

  • Be an active CLS member.
  • Content should complement CLS’s mission of empowering our life sciences community to deliver innovative solutions for healthier lives.
  • Highlight your current organizational initiatives, press releases, patient stories, recent news articles, challenges and opportunities for our industry, areas of focus, major milestones, success stories, etc.
  • Include a high-resolution .png or .jpg logo
  • No more than two organizational submissions per month

*Spotlight submissions will be selected at the discretion of CLS and featured in our monthly newsletter.

Content Archive

2025

2024